Harpreet S Wasan

Author PubWeight™ 13.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. Lancet 2011 4.36
2 Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study. Lancet Oncol 2011 3.44
3 A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). J Hepatol 2012 1.31
4 FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer. BMC Cancer 2014 0.90
5 Kinetic filtering of [(18)F]Fluorothymidine in positron emission tomography studies. Phys Med Biol 2010 0.89
6 Assessment of global liver blood flow with quantitative dynamic contrast-enhanced ultrasound. J Ultrasound Med 2011 0.81
7 Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy. Cardiovasc Intervent Radiol 2010 0.81
8 Reproducibility of quantitative assessment of altered hepatic hemodynamics with dynamic contrast-enhanced ultrasound. J Ultrasound Med 2012 0.79
9 Embolisation of the gastroduodenal artery is not necessary in the presence of reversed flow before yttrium-90 radioembolisation. Cardiovasc Intervent Radiol 2011 0.77
10 Cost of selective internal radiation therapy versus other modalities. Future Oncol 2014 0.75
11 Evidence-based integration of selective internal radiation therapy in the management of colorectal liver metastases. Future Oncol 2014 0.75